Navigation Links
NeoGenomics to Present at Noble Financial's 5th Annual Equity Conference on Monday, June 8th

FT. MYERS, Fla., June 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM) today announced that it will present at the Fifth Annual Noble Financial Equity Conference at 9:15 AM EDT on Monday, June 8, 2009 at the Seminole Hard Rock Hotel in Hollywood, FL. Robert Gasparini, the Company's President and Chief Scientific Officer will give a presentation regarding NeoGenomics' market positioning, financial performance, and strategic direction and then answer questions from the audience. The presentation will be webcast LIVE featuring high-definition, streaming video and PowerPoint slides. Access is available by logging on to In addition, a portal to the webcast will be available in the Investor Relations section of the NeoGenomics' website at It is recommended that interested parties register at least 10 minutes prior to the start of the presentation to ensure timely access to the webcast.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit

For more news and information on NeoGenomics, please visit where you can find a fact sheet on the company, investor presentations, and more. Interested parties can also access additional investor relations material, including an investment profile and an equity research report, from Hawk Associates at or from the American Microcap Institute at

About Noble Financial

Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms - uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences - 2009 marks their fifth annual - allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 25 years and has offices in Florida, New York City and Boston.

SOURCE NeoGenomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
2. NeoGenomics Schedules its Q1 2009 Earnings Release for April 23, 2009
3. NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
4. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
5. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
6. NeoGenomics to Present at the Noble Financial Equity Conference
7. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
8. NeoGenomics Announces Results for the 3rd Quarter 2007
9. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
10. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
11. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
Post Your Comments:
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... lecturer at a University of Delaware Accounting and Management of Information Systems course. ... solutions for mid-market businesses. Sommer will speak at before student in the Enterprise ...
(Date:11/30/2015)... Doylestown, PA (PRWEB) , ... November 30, 2015 , ... ... the 15th annual Regional Biotech Conference, organized by the Baruch S. Blumberg Institute. , ... than 100 of the area’s life science and biotechnology leaders for the conference, which ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... teams looking to maximize recovery through quality sleep. Tim DiFrancesco, training coach for ... a better night’s sleep. ChiliPad precisely regulates the surface temperature of each side ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... Dr. ... With three office locations, patients can visit Dr. Margulies to experience the best available ... to hold the title of "NJ Top Dentist"! , Orthodontics is the branch of ...
(Date:11/30/2015)... ... November 30, 2015 , ... The recently published 32nd ... System (NPDS) reveals that in 2014, someone called a poison center about every ... of which were human exposure cases. , The American Association of Poison Control ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... REDWOOD CITY, Calif. , Nov. 30, 2015 ... company that is providing innovative evidence-based solutions for the treatment ... Appeals Board (PTAB) at the U.S. Patent and Trademark Office ... (IPR) of U.S. Patent No. 8,359,102 (the ,102 patent).  ... 14, 2015, a unit of Boston Scientific Corporation filed two ...
(Date:11/30/2015)... AMSTERDAM , Nov. 30, 2015   ... today announced the launch of Radiology Solutions, a ... management. Radiology Solutions comprises customized, data-driven practice management ... analytics to help radiology practices improve care delivery ... 2015 Radiological Society of North America Annual ...
(Date:11/30/2015)... AMSTERDAM , Nov. 30, 2015   Royal ... introduced ScanWise Implant, the industry,s first MRI guided user ... the scanning of patients with MR Conditional implants, such ... at the 2015 Radiological Society of North America ... streamline exams and supports diagnostic confidence of this growing ...
Breaking Medicine Technology: